Analyst ratings, especially from reputable firms like BTIG, can significantly influence investor sentiment and stock prices. A Buy rating combined with a high price target suggests a strong bullish outlook for Janux Therapeutics, potentially leading to increased investor interest and a positive short-term price movement.